knowledge -WSS

knowledge

author：focus 2025-09-28 00:50:43 - browse：9

A view of different flags of the European Union Members. -- first opinion coverage from STAT — Ronald Wittek, Pool Photo via AP

Today, the criteria used to assess the clinical value of new pharmaceuticals and medical devices varies widely across Europe, making it more challenging for biopharma companies to efficiently launch products in multiple countries and contributing to the disparities in access across the continent.

But change is on the horizon: In less than 15 months, the European Union will establish and begin to implement a standardized, pan-EU framework, which all 27 of member states will be required to use to assess the clinical evidence of newly submitted products or devices. A key pillar of the EU’s Regulation on Health Technology Assessment (HTA), the Joint Clinical Assessment (JCA) aims to establish a single, transparent process to reduce redundant practices and bring life science innovation faster to patients in Europe — no matter where they live.

In a longstanding problem in Europe, access to — and the availability of — medication varies across the member states. For example, in Germany, 87% of products approved by the European Medicines Agency (EMA) have full availability (the product gained access on the public reimbursement list without any restrictions to the patient population). In Poland, that figure drops to 8%, according to a report published by the European Federation of Pharmaceutical Industries. Meanwhile, there is a tremendous difference in the gap between an oncology therapy receiving marketing authorization and a formal positive reimbursement decision, ranging from an average of 86 days in Denmark to 981 days in Latvia.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Indian pharmaceutical industry in denial over drug

hotspot

knowledge

WSS

Ozempic has benefits for kidney disease as well as diabetes

State of the Union pitch: Bigger Medicare drug price negotiations

Public funding for King Charles III and royals has been recalculated due to windfarm deal profits

Biden's 'march

Streamlined flu vaccines recommended by FDA advisory panel

The public health thinking behind the CDC’s new Covid guidance

knowledge

knowledge

knowledge

23andMe had bad news about my health. I wish a person had delivered it

Harvard's David Sinclair gets blowback over aging

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Divers poised to search for children washed away in Pennsylvania flash flood

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Wife of Gilgo Beach murder suspect files for divorce, court filing shows

As demand for Covid shots wanes, Moderna seeks its next success

Fetal cell organoids grown from amniotic fluid, study finds

Psychedelics group wrestles with new pharma identity

Texas Department of Public Safety speaks out on migrant abuse allegations

focus

Mass General totes up its waste in a move to tackle climate change

I learned firsthand about improving diversity in clinical trials

Biden's 'march

Lack of health data on LGBTQ+ people has serious consequences

Fetal cell organoids grown from amniotic fluid, study finds

Winning ticket for $1 billion Powerball jackpot sold in California

hotspot

hotspot

knowledge

knowledge